Adagene ADAG
NASDAQ ADAG
$3.58 -0.11 (-2.98%)
As of: Sep 4, 2026 · 3:59 PM EDT

Adagene (ADAG) Other Accumulated Expenses (2019 - 2025)

Adagene (ADAG) posted quarterly Other Accumulated Expenses of $10.3 million for Q4 2025, down 21.54% year-over-year from $13.2 million in Q4 2024, and down 28.39% quarter-over-quarter from $14.4 million in Q2 2025.

Analysis

Adagene (ADAG) Other Accumulated Expenses (2019 - 2025) Analysis & Trends

Adagene (ADAG) has reported Other Accumulated Expenses for 7 consecutive years, with $10.3 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Other Accumulated Expenses fell 21.54% year-over-year to $10.3 million; the TTM figure through Dec 2025 stood at $10.3 million (down 21.54% YoY), while the FY2025 annual figure was $10.3 million, down 21.54% from the prior year.
  • Other Accumulated Expenses fell to $10.3 million in Q4 2025 per ADAG's latest filing, from $14.4 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $19.3 million in Q4 2022 and bottomed at $143060.0 in Q4 2021.
  • Historically, Other Accumulated Expenses has averaged $13.1 million across 5 years, with a median of $14.4 million in 2025.
  • Annual changes were most pronounced in 2022 — Other Accumulated Expenses soared 13407.16% — and 2025, when it slipped 21.54%.
  • Adagene's Other Accumulated Expenses stood at $143060.0 in 2021, then jumped by 13407.16% to $19.3 million in 2022, then dropped by 13.5% to $16.7 million in 2023, then slipped by 21.1% to $13.2 million in 2024, then slipped by 21.54% to $10.3 million in 2025.
  • Business Quant data shows ADAG's Other Accumulated Expenses at $10.3 million in Q4 2025, $14.4 million in Q2 2025, and $13.2 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Adagene 211.24 Mn 211.24 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 10.35 Mn
Jun 30, 2025 14.45 Mn
Dec 31, 2024 13.19 Mn
Jun 30, 2024 17.33 Mn
Dec 31, 2023 16.71 Mn
Dec 31, 2022 19.32 Mn
Dec 31, 2021 143,060.00
Dec 31, 2020 145,664.00
Dec 31, 2019 -15.80 Mn